| Jaleh Sue Garman, AUD | |
|
600 N Wolfe St, Baltimore, MD 21287-0005 | |
| (410) 955-9441 | |
| Not Available |
| Full Name | Jaleh Sue Garman |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 31 Years |
| Location | 600 N Wolfe St, Baltimore, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962456418 | NPI | - | NPPES |
| 795538300 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 00719 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Johns Hopkins University | 8921903147 | 2692 |
News Archive
Edmonton - Adding ezetimibe to atorvastatin significantly boosted the attainment of lipid targets as specified by both Canadian and European guidelines in elderly patients aged 65 and older and the combination produced superior results than simply increasing the dose of atorvastatin alone, Dr. Christian Constance told the Canadian Cardiovascular Congress 2009, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.
In the first genome-wide search for the genetic roots of the most common form of amyotrophic lateral sclerosis (ALS), Johns Hopkins scientists have newly identified 34 unique variations in the human genetic code among 276 unrelated subjects with ALS.
Patients with heart failure who felt socially isolated were much more likely to die or be hospitalized than more socially connected patients, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.
Genentech, a member of the Roche Group, and Biogen Idec today announced the U.S. Food and Drug Administration approved Rituxan as a maintenance treatment for patients with advanced follicular lymphoma who responded to initial treatment with Rituxan plus chemotherapy.
AMGEN today announced additional results from a pivotal Phase 3 trial evaluating talimogene laherparepvec in patients with unresected stage IIIB, IIIC or IV melanoma compared to granulocyte-macrophage colony-stimulating factor (GM-CSF).
› Verified 3 days ago
| Provider Name | Johns Hopkins University |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1922008549 PECOS PAC ID: 8921903147 Enrollment ID: O20031215000719 |
News Archive
Edmonton - Adding ezetimibe to atorvastatin significantly boosted the attainment of lipid targets as specified by both Canadian and European guidelines in elderly patients aged 65 and older and the combination produced superior results than simply increasing the dose of atorvastatin alone, Dr. Christian Constance told the Canadian Cardiovascular Congress 2009, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.
In the first genome-wide search for the genetic roots of the most common form of amyotrophic lateral sclerosis (ALS), Johns Hopkins scientists have newly identified 34 unique variations in the human genetic code among 276 unrelated subjects with ALS.
Patients with heart failure who felt socially isolated were much more likely to die or be hospitalized than more socially connected patients, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.
Genentech, a member of the Roche Group, and Biogen Idec today announced the U.S. Food and Drug Administration approved Rituxan as a maintenance treatment for patients with advanced follicular lymphoma who responded to initial treatment with Rituxan plus chemotherapy.
AMGEN today announced additional results from a pivotal Phase 3 trial evaluating talimogene laherparepvec in patients with unresected stage IIIB, IIIC or IV melanoma compared to granulocyte-macrophage colony-stimulating factor (GM-CSF).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jaleh Sue Garman, AUD 6201 Greenleigh Ave, Middle River, MD 21220-2004 Ph: () - | Jaleh Sue Garman, AUD 600 N Wolfe St, Baltimore, MD 21287-0005 Ph: (410) 955-9441 |
News Archive
Edmonton - Adding ezetimibe to atorvastatin significantly boosted the attainment of lipid targets as specified by both Canadian and European guidelines in elderly patients aged 65 and older and the combination produced superior results than simply increasing the dose of atorvastatin alone, Dr. Christian Constance told the Canadian Cardiovascular Congress 2009, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.
In the first genome-wide search for the genetic roots of the most common form of amyotrophic lateral sclerosis (ALS), Johns Hopkins scientists have newly identified 34 unique variations in the human genetic code among 276 unrelated subjects with ALS.
Patients with heart failure who felt socially isolated were much more likely to die or be hospitalized than more socially connected patients, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.
Genentech, a member of the Roche Group, and Biogen Idec today announced the U.S. Food and Drug Administration approved Rituxan as a maintenance treatment for patients with advanced follicular lymphoma who responded to initial treatment with Rituxan plus chemotherapy.
AMGEN today announced additional results from a pivotal Phase 3 trial evaluating talimogene laherparepvec in patients with unresected stage IIIB, IIIC or IV melanoma compared to granulocyte-macrophage colony-stimulating factor (GM-CSF).
› Verified 3 days ago
Ms. Terese D Beauchamp, M.S. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 7658a Belair Rd, Baltimore, MD 21236 Phone: 410-668-9198 | |
Shannon Hahn, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 200 E 33rd St, Baltimore, MD 21218 Phone: 410-554-4455 | |
Total Audiology Llc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 733 W 40th St Ste 20, Baltimore, MD 21211 Phone: 410-877-0795 Fax: 877-766-8925 | |
Estelle Skinner, MS, CCC/A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2500 E Northern Pkwy, Baltimore, MD 21214 Phone: 410-515-6548 | |
Devra Brace, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 6565 N Charles St Ste 601, Baltimore, MD 21204 Phone: 410-821-5151 Fax: 410-823-8309 | |
Ms. Cynthia Ann Fannon, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 6565 N Charles St, Suite 601, Baltimore, MD 21204 Phone: 410-821-5151 | |
Erin Mcdermott, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 3801 Gough St, Baltimore, MD 21224 Phone: 131-572-0456 |